Kym Young Ph.D. has received a five-year career development grant to investigate a new neurobehavioral treatment for major depressive disorder.
Major depressive disorder (MDD) is the leading cause of years lived with disability worldwide. Traditional pharmacological and/or psychological interventions are ineffective in up to one-half of patients, and treatments (such as electroconvulsive therapy, vagus nerve stimulation, and deep brain stimulation) available for severely ill patients who do not respond to standard interventions are invasive, and potentially associated with significant side effects. Therefore, there is a need to explore and develop novel non-invasive treatments, which is the goal of Dr. Young's grant.
Major depressive disorder (MDD) is the leading cause of years lived with disability worldwide. Traditional pharmacological and/or psychological interventions are ineffective in up to one-half of patients, and treatments (such as electroconvulsive therapy, vagus nerve stimulation, and deep brain stimulation) available for severely ill patients who do not respond to standard interventions are invasive, and potentially associated with significant side effects. Therefore, there is a need to explore and develop novel non-invasive treatments, which is the goal of Dr. Young's grant.
RSS Feed